Skip to main content

Table 1 Overview of the pharmacokinetic (PK) parameters in plasma

From: The impact of therapeutic-dose induced intestinal enrofloxacin concentrations in healthy pigs on fecal Escherichia coli populations

PK parameters

Group 1

PO

2.5 mg ENR/ kg BW

Group 2

PO

1.25 mg ENR/ kg BW

Group 3

IM

2.5 mg ENR/ kg BW

Group 4

IM

5 mg ENR/ kg BW

Cmax (μg/mL)

0.45 ± 0.080a

0.18 ± 0.017b

0.57 ± 0.14a

1.02 ± 0.15c

Tmax (h)

2.25 ± 1.48a

2.00 ± 0.63a

2.50 ± 0.84a

4.00 ± 2.10a

AUC0–24 h (h*μg/mL)

5.93 ± 1.16a

2.02 ± 0.18b

6.88 ± 1.93a

12.26 ± 1.83c

AUC0–58 h (h*μg/mL)

14.98 ± 2.13a

6.08 ± 1.40b

16.13 ± 3.87a

28.50 ± 3.65c

AUC0–58 h/D

8.96 10− 4 ±

4.63 10− 4 a

8.54 10− 4 ±

6.66 10− 4 a

8.59 10− 4 ±

3.81 10− 4 a

8.18 10− 4 ±

2.45 10− 4 a

Cpss (μg/mL)

0.25 ± 0.049a

0.092 ± 0.021b

0.29 ± 0.081a

0.51 ± 0.076c

  1. Overview of the area under the curve from 0 to 24 h (AUC0–24 h), maximal plasma concentration of ENR (Cmax), and time of Cmax (Tmax) for groups 1, 2, 3 and 4 after the first administration (0–24 h). Also, the AUC0–58 h values (3 treatment days days), AUC0–58 h values normalized for dose (D) administered (AUC0–58 h/D) and the steady state plasma concentrations (Cpss) for groups 1, 2, 3 and 4 are given. A difference in superscripts a, b or c denotes a statistical significant difference between these groups. Statistics were exerted using a single-factor ANOVA with a post-hoc Tukey test (equality of variances checked), significance level 0.05. For AUC0–58h/D an independent-samples T test was used to compare the mean values between group 1–2 and 3–4